Five European anti-cancer charities (Fundación científica Asociación Española Contra el Cáncer (Spain); The Anticancer Fund (Belgium); Fondation ARC (France); Kom op tegen Kanker (Belgium); Dutch Cancer Society (The Netherlands)) are joining forces to stimulate international research on rare cancer drug development. The focus of this joint international call, the ATTRACT-Call, is on late phase (2/3) clinical trials on rare cancer drugs. Improving treatment for rare cancers as well as bringing drug development to the next developmental stage are two of the current target goals.
The target opening date of the ATTRACT-Call is Tuesday, 22 November 2022. Grant decisions are foreseen in November 2023. Detailed and definitive timelines will follow.
More information here: https://www.kwf.nl/en/attract